Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Change in Accured Expenses (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Change in Accured Expenses for 11 consecutive years, with $832458.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses fell 24.34% to $832458.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$854790.0, a 151.22% decrease, with the full-year FY2024 number at -$483250.0, up 58.99% from a year prior.
  • Change in Accured Expenses was $832458.0 for Q3 2025 at KORU Medical Systems, up from -$176262.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q3 2023 to a low of -$1.6 million in Q4 2024.
  • A 5-year average of -$35380.9 and a median of $25625.0 in 2022 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: tumbled 2259.7% in 2021, then surged 245.25% in 2023.
  • KORU Medical Systems' Change in Accured Expenses stood at $672856.0 in 2021, then plummeted by 171.81% to -$483207.0 in 2022, then tumbled by 194.24% to -$1.4 million in 2023, then dropped by 10.06% to -$1.6 million in 2024, then surged by 153.2% to $832458.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Change in Accured Expenses are $832458.0 (Q3 2025), -$176262.0 (Q2 2025), and $53803.0 (Q1 2025).